Sarah E. Weiser

Effects of transportation of IV bags containing protein formulations via hospital pneumatic tube system: Particle characterization by multiple methods.

J. Carpenter, L. Crawford, P. Kolhe, 2022, Journal of pharmaceutical sciences.

An Industry Perspective on Compatibility Assessment of Closed System Drug-Transfer Devices for Biologics.

Richard J. Galas, Ahmed Besheer, C. Zamiri, 2020, Journal of pharmaceutical sciences.

Physicochemical stability of PF-05280014 (trastuzumab-qyyp; TrazimeraTM), a trastuzumab biosimilar, under extended in-use conditions

E. Zartler, Sarah Weiser, Christopher Burns, 2022, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Physicochemical stability of PF-06439535 (bevacizumab-bvzr; Zirabev®), a bevacizumab biosimilar, under extended in-use conditions

E. Zartler, Christopher Burns, Sarah E. Weiser, 2022, Journal of Oncology Pharmacy Practice.

Development of the Drug Product Formulation of the Bevacizumab Biosimilar PF-06439535 (Bevacizumab-bvzr)

Sarah E. Weiser, Rebecca L Ingram, 2023, Drugs in R&D.

Challenges of using closed system transfer devices with biological drug products - An industry perspective.

C. Zamiri, A. Sreedhara, S. Goswami, 2019, Journal of pharmaceutical sciences.

Best Practices for Microbial Challenge In-use Studies to Evaluate the Microbial Growth Potential of Parenteral Biological Products; Industry and Regulatory Considerations.

C. Zamiri, P. Goldbach, G. Gopalrathnam, 2023, PDA journal of pharmaceutical science and technology.

Current Industry Best Practice on In-Use Stability and Compatibility Studies for Biological Products.

M. Blümel, J. Litowski, D. Shekhawat, 2023, Journal of pharmaceutical sciences.

An Industry Perspective on the Challenges of Using Closed System Transfer Devices with Biologics and Communication Guidance to Healthcare Professionals.

C. Zamiri, Lori Burton, Twinkle R. Christian, 2021, Journal of pharmaceutical sciences.